Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 The developmental origins of health and disease: an overview
- 2 The ‘developmental origins’ hypothesis: epidemiology
- 3 The conceptual basis for the developmental origins of health and disease
- 4 The periconceptional and embryonic period
- 5 Epigenetic mechanisms
- 6 A mitochondrial component of developmental programming
- 7 Role of exposure to environmental chemicals in developmental origins of health and disease
- 8 Maternal nutrition and fetal growth and development
- 9 Placental mechanisms and developmental origins of health and disease
- 10 Control of fetal metabolism: relevance to developmental origins of health and disease
- 11 Lipid metabolism: relevance to developmental origins of health and disease
- 12 Prenatal hypoxia: relevance to developmental origins of health and disease
- 13 The fetal hypothalamic–pituitary–adrenal axis: relevance to developmental origins of health and disease
- 14 Perinatal influences on the endocrine and metabolic axes during childhood
- 15 Patterns of growth: relevance to developmental origins of health and disease
- 16 The developmental environment and the endocrine pancreas
- 17 The developmental environment and insulin resistance
- 18 The developmental environment and the development of obesity
- 19 The developmental environment and its role in the metabolic syndrome
- 20 Programming the cardiovascular system
- 21 The role of vascular dysfunction in developmental origins of health and disease: evidence from human and animal studies
- 22 The developmental environment and atherogenesis
- 23 The developmental environment, renal function and disease
- 24 The developmental environment: effect on fluid and electrolyte homeostasis
- 25 The developmental environment: effects on lung structure and function
- 26 Developmental origins of asthma and related allergic disorders
- 27 The developmental environment: influences on subsequent cognitive function and behaviour
- 28 The developmental environment and the origins of neurological disorders
- 29 The developmental environment: clinical perspectives on effects on the musculoskeletal system
- 30 The developmental environment: experimental perspectives on skeletal development
- 31 The developmental environment and the early origins of cancer
- 32 The developmental environment: implications for ageing and life span
- 33 Developmental origins of health and disease: implications for primary intervention for cardiovascular and metabolic disease
- 34 Developmental origins of health and disease: public-health perspectives
- 35 Developmental origins of health and disease: implications for developing countries
- 36 Developmental origins of health and disease: ethical and social considerations
- 37 Past obstacles and future promise
- Index
- References
7 - Role of exposure to environmental chemicals in developmental origins of health and disease
Published online by Cambridge University Press: 08 August 2009
Book contents
- Frontmatter
- Contents
- List of contributors
- Preface
- 1 The developmental origins of health and disease: an overview
- 2 The ‘developmental origins’ hypothesis: epidemiology
- 3 The conceptual basis for the developmental origins of health and disease
- 4 The periconceptional and embryonic period
- 5 Epigenetic mechanisms
- 6 A mitochondrial component of developmental programming
- 7 Role of exposure to environmental chemicals in developmental origins of health and disease
- 8 Maternal nutrition and fetal growth and development
- 9 Placental mechanisms and developmental origins of health and disease
- 10 Control of fetal metabolism: relevance to developmental origins of health and disease
- 11 Lipid metabolism: relevance to developmental origins of health and disease
- 12 Prenatal hypoxia: relevance to developmental origins of health and disease
- 13 The fetal hypothalamic–pituitary–adrenal axis: relevance to developmental origins of health and disease
- 14 Perinatal influences on the endocrine and metabolic axes during childhood
- 15 Patterns of growth: relevance to developmental origins of health and disease
- 16 The developmental environment and the endocrine pancreas
- 17 The developmental environment and insulin resistance
- 18 The developmental environment and the development of obesity
- 19 The developmental environment and its role in the metabolic syndrome
- 20 Programming the cardiovascular system
- 21 The role of vascular dysfunction in developmental origins of health and disease: evidence from human and animal studies
- 22 The developmental environment and atherogenesis
- 23 The developmental environment, renal function and disease
- 24 The developmental environment: effect on fluid and electrolyte homeostasis
- 25 The developmental environment: effects on lung structure and function
- 26 Developmental origins of asthma and related allergic disorders
- 27 The developmental environment: influences on subsequent cognitive function and behaviour
- 28 The developmental environment and the origins of neurological disorders
- 29 The developmental environment: clinical perspectives on effects on the musculoskeletal system
- 30 The developmental environment: experimental perspectives on skeletal development
- 31 The developmental environment and the early origins of cancer
- 32 The developmental environment: implications for ageing and life span
- 33 Developmental origins of health and disease: implications for primary intervention for cardiovascular and metabolic disease
- 34 Developmental origins of health and disease: public-health perspectives
- 35 Developmental origins of health and disease: implications for developing countries
- 36 Developmental origins of health and disease: ethical and social considerations
- 37 Past obstacles and future promise
- Index
- References
Summary
Introduction
Between two and five per cent of all live-born infants have a major developmental defect. Up to 40 per cent of these defects have been estimated to result from maternal exposure(s) to harmful environmental agents that directly or indirectly create an unfavourable intrauterine environment. A spectrum of adverse effects can occur, including death, structural malformation, and/or functional alteration of the fetus/embryo. The traditional focus of the science of developmental toxicology has been on the role of agents (environmental or drugs) that cause either premature death of the fetus or birth defects. In recent years, attention has turned to examining the effects of in-utero or neonatal exposure to environmental agents on functional changes in tissues, e.g. permanent changes in tissue function that are not the result of overtly or grossly teratogenic effects but that result in increased susceptibility to disease/dysfunction later in life.
The epidemiology data that support the concept of the fetal basis of adult disease, together with the preliminary data showing alterations in gene expression and tissue imprinting due to in-utero exposures to some environmental agents, provide an attractive framework for understanding delayed functional effects of toxicant exposures. We propose that exposure to certain environmental chemicals, alone or in combination with altered nutrition, leads to aberrant developmental programming that permanently alters gland, organ or system potential.
- Type
- Chapter
- Information
- Developmental Origins of Health and Disease , pp. 82 - 97Publisher: Cambridge University PressPrint publication year: 2006
References
Abbott, D. H., Dumesic, D. A., Eisner, J. W., Kemnitz, R. J. and Goy, R. W. (1997). The prenatally androgenized female rhesus monkey as a model for polycystic ovarian syndrome. In Androgen Excess Disorders in Women, (ed. , and ). Philadelphia, PA: Lippincott-Raven, pp. 369–82.Google Scholar
, and (2002). Developmental origins of polycystic ovary syndrome: a hypothesis. J. Endocrinol., 174, 1–5.CrossRefGoogle Scholar
, , , and (2004). Inhibition of testicular steroidogenesis by the xenoestrogen bisphenol A is associated with reduced pituitary luteinizing hormone secretion and decreased steroidogenic enzyme gene expression in rat Leydig cells. Endocrinology, 145, 592–603.CrossRefGoogle ScholarPubMed
, and (2004). Developmental exposure to chlorpyrifos elicits sex-selective alterations of serotonergic synaptic function in adulthood: critical periods and regional selectivity for effects on the serotonin transporter, receptor subtypes, and cell signaling. Environ. Health Perspect., 112, 148–55.CrossRefGoogle ScholarPubMed
, , et al. (2002). Uterine responsiveness to estradiol and DNA methylation are altered by fetal exposure to diethylstilbestrol and methoxychlor in CD-1 mice: effects of low versus high doses. Toxicol. Appl. Pharmacol., 183, 10–22.CrossRefGoogle ScholarPubMed
, , et al. (2001). Site-specific regulation of oestrogen receptor a and b by estradiol in human adipose tissue. Diabetes Obes. Metab., 3, 338–49.CrossRefGoogle Scholar
, , and (2005). Epigenetic transgenerational actions of endocrine disruptors on male fertility. Science, 308, 1466–9.CrossRefGoogle ScholarPubMed
(2002). Chemical toxins: a hypothesis to explain the global obesity epidemic. J. Altern. Complement. Med., 8, 185–92.CrossRefGoogle ScholarPubMed
Bern, H. (1992). The fragile fetus. In Chemically Induced Alterations in Sexual and Functional development: the Wildlife/Human Connection (ed. and ). Princeton: Princeton Scientific Publishing, pp. 9–15.Google Scholar
and (2002). Beneficial role of dietary phytoestrogens in obesity and diabetes. Am. J. Clin. Nutr., 76, 1191–201.CrossRefGoogle ScholarPubMed
and (2003). Cancer and developmental exposures to endocrine disruptors. Environ. Health Perspect., 111, 389–94.CrossRefGoogle ScholarPubMed
, , , and (1998). Prenatal TCDD and predisposition to mammary cancer in the rat. Carcinogenesis, 19, 1623–9.CrossRefGoogle ScholarPubMed
, , et al. (2003). Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. J. Biol. Chem., 278, 28668–76.CrossRefGoogle ScholarPubMed
, , , and (2004). Maternal stress modulates the effects of developmental lead exposure. Environ. Health Perspect., 112, 717–30.CrossRefGoogle ScholarPubMed
, , et al. (1998). Effects of prenatal and postnatal methylmercury exposures from fish consumption on neurodevelopment: outcomes at 66 months of age in the Seychelles Child Development Study. JAMA, 280, 701–7.CrossRefGoogle Scholar
(1999). Exposure to lead during development alters aggressive behavior in golden hamsters. Neurotoxicol. Teratol., 21, 445–9.CrossRefGoogle ScholarPubMed
, , and (2002). Ovarian hyperandrogenism in adult female rhesus monkeys exposed to prenatal androgen excess. Fertil. Steril., 77, 167–72.CrossRefGoogle ScholarPubMed
, , and (2002). Persistant abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Sci., 67, 63–74.CrossRefGoogle Scholar
and (1999). Persistent suppression of delayed-type hypersensitivity in adult F344 rats after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology, 134, 79–88.CrossRefGoogle ScholarPubMed
, , and (1997). Alterations in the developing immune system of the F344 rat after prenatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin II: effects on the pup and the adult. Toxicology, 122, 229–40.CrossRefGoogle ScholarPubMed
, , et al. (1997). Cognitive deficits in 7-year old children with prenatal exposures to methylmercury. Neurotoxicol. Teratol., 19, 417–28.CrossRefGoogle Scholar
, , and (1999). Environmental antiandrogens: low doses of the fungicide vinclozolin alter sex differentiation of the male rat. Toxicol. Ind. Health, 15, 48–64.CrossRefGoogle ScholarPubMed
(2003). Endocrine disruptors and the obesity epidemic. Toxicol. Sci., 76, 247–9.CrossRefGoogle ScholarPubMed
, , and (1971). Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumour appearance in young women. N. Engl. J. Med., 284, 878–81.CrossRefGoogle ScholarPubMed
, , , and (1999). Maternal exposure to genistein during pregnancy increases carcinogen-induced mammary tumourigenesis in female rat offspring. Oncol. Rep., 6, 1089–95.Google Scholar
(1999). Prenatal immunotoxicant exposure and postnatal autoimmune disease. Environ. Health Perspect., 107 (suppl. 5), 687–91.CrossRefGoogle ScholarPubMed
, , , , and (1993). Selective prothymocyte targeting by prenatal diethylstilbestrol exposure. Cell. Immunol., 152, 131–42.CrossRefGoogle Scholar
, , , and (2004). Effects of genistein or soy milk during late gestation and lactation on adult uterine organisation in the rat. Exp. Biol. Med., 229, 108–17.CrossRefGoogle ScholarPubMed
, , et al. (2003). Bisphenol A exposure causes meiotic aneuploidy in the female mouse. Curr. Biol., 13, 546–53.CrossRefGoogle ScholarPubMed
and (2004). Prenatal exposure to polychlorinated biphenols and attention at school age. Obstet. Gynecol. Surv., 59, 412–13.CrossRefGoogle Scholar
, , , and (2002). Neonatal exposure to genistein induces oestrogen receptor (ERa) expression and multioocyte follicles in the maturing mouse ovary: evidence for ERb-mediated and nonestrogenic actions. Biol. Reprod., 67, 1285–96.CrossRefGoogle Scholar
, , , and (in press). Neonatal genistein exposure induces oestrogen receptor mediated alterations in gene expression in the developing mouse uterus: differential effects of low versus high doses. Mol. Endocrinol.Google Scholar
and (2002). The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415–28.CrossRefGoogle Scholar
, and (2001). Estrogen receptors in human preadipocytes. Endocrine, 15, 225–30.CrossRefGoogle ScholarPubMed
, and (2003). The regulation and biological significance of genomic imprinting. J. Biochem., 133, 699–711.CrossRefGoogle ScholarPubMed
, , , and (2004). Neonatal exposure to diethylstilbestrol leads to impaired action of androgens in adult male hamsters. Reprod. Toxicol., 19, 53–63.CrossRefGoogle ScholarPubMed
, and (1998). Antiandrogens as environmental endocrine disruptors. Reprod. Fertil. Dev., 10, 105–11.CrossRefGoogle ScholarPubMed
, , , and (2003). Effects of neonatal treatment with phytoestrogens, genestein and daidzein on sex difference in female rat brain function: estrous cycle and lordosis. Horm. Behav., 44, 140–5.CrossRefGoogle ScholarPubMed
(2005). Fetal nicotinic overload, blunted sympathetic responsivity and weight gain. Birth Defects Res. A Clin. Mol. Teratol., epub. June 2005.CrossRefGoogle Scholar
, , , and (2003). Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation of its exon-4 in mouse uterus. Mol. Carcinog., 38, 78–84.CrossRefGoogle ScholarPubMed
, , , and (2003). Region-specific inhibition of prostatic epithelial bud formation in the urogenital sinus of C57BL/6 mice exposed in-utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci., 76, 171–81.CrossRefGoogle ScholarPubMed
, , , , and (2004). Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience, 124, 619–28.CrossRefGoogle ScholarPubMed
, , , and (2004). Androgen receptor expression in the rat prostate is down regulated by dietary phytoestrogens. Reprod. Biol. Endocrinol., 16, 5–11.CrossRefGoogle Scholar
, , and (1996). Glycine and calcium-dependent effects of lead on N-methyl-D-aspartate receptor function in rat hippocampal neurons. J. Pharmacol. Exp. Ther., 279, 143–53.Google ScholarPubMed
, , , and (2001). In utero exposure to bisphenol A alters the development and tissue organisation of the mouse mammary gland. Biol. Reprod., 65, 1215–23.CrossRefGoogle ScholarPubMed
, , , et al. (2002). Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J. Lipid Res., 43, 676–84.Google ScholarPubMed
, and (1980). Long term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res., 40, 3988–99.Google ScholarPubMed
, , and (2001). From malformations to molecular mechanisms in the male: three decades of research on endocrine disruptors. APMIS, 109, 263–72.CrossRefGoogle Scholar
, , and (2004). Estrogen-independent activation of erbBs signaling and estrogen receptor α in the mouse vagina exposed neonatally to diethylstilbestrol. Oncogene, 23, 340–9.CrossRefGoogle ScholarPubMed
, , et al. (2002). Application of toxicogenomic analysis to risk assessment of delayed long-term effects of multiple chemicals, including endocrine disruptors in human fetuses. Environ. Health Perspect., 111, 803–9.Google Scholar
and (2003). Imprinting evolution and the price of silence. Bioessays, 25, 577–88.CrossRefGoogle Scholar
, , et al. (2003). The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology, 144, 3315–20.CrossRefGoogle ScholarPubMed
, , , and (2003). Exposure of neonatal rats to diethylstilbestrol affects the expression of genes involved in ovarian differentiation. J. Med. Dent. Sci., 50, 35–40.Google ScholarPubMed
(2001). Epigenetics: interaction of DNA methylation and chromatin. Gene, 278, 25–31.CrossRefGoogle ScholarPubMed
and (2000). Assessing children's exposure to hazardous environmental chemicals: an overview of selected research challenges and complexities. J. Expos. Anal. Environ. Epidemiol., 10, 611–29.CrossRefGoogle ScholarPubMed
, , , and (2002). Bone lead levels in adjudicated delinquents. A case control study. Neurotoxicol. Teratol., 24, 711–17.CrossRefGoogle ScholarPubMed
, and (1990). Uterine adenocarcinoma in mice following developmental treatment with oestrogens: a model for hormonal carcinogenesis. Cancer Res., 50, 7677–81.Google ScholarPubMed
, , and (2001). Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res., 61, 4325–8.Google ScholarPubMed
, , and (2004). Developmental exposure to diethylstilbestrol (DES) alters uterine response to oestrogens in prepubescent mice: low versus high dose effects. Rep. Toxicol. 18, 399–406.CrossRefGoogle ScholarPubMed
, , et al. (2002). Epigenomics: genome-wide study of methylation phenomena. Curr. Issues. Mol. Biol., 4, 111–28.Google ScholarPubMed
, , and (1998). Prenatal exposure to androgens leads to the development of cystic ovaries in the sheep. Biol. Reprod. 56 (Suppl. l), 194–9.Google Scholar
, , et al. (2002). Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). Cancer Causes Control, 13, 753–8.CrossRefGoogle Scholar
, , , and (2003). Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood. Environ. Health Perspect., 111, 536–44.CrossRefGoogle ScholarPubMed
, , , , and (2001). Prenatal exposure to low doses of bisphenol A alters the periductal stroma and glandular cell function in the rat ventral prostate. Biol. Reprod., 65, 1271–7.CrossRefGoogle ScholarPubMed
, and (2003). Mammalian epigenomics: reprogramming the genome for development and therapy. Theriogenology, 59, 21–32.CrossRefGoogle ScholarPubMed
(1996). Behavioral effects of lead: commonalities between experimental and epidemiologic data. Environ. Health Perspect., 104 (Suppl. 2), 337–51.CrossRefGoogle ScholarPubMed
, , , and (2004). Early exposure to lead and neuropsychological outcome in adolescence. J. Int. Neuropsychol. Soc., 10, 261–70.CrossRefGoogle ScholarPubMed
, and the EURO-BLCS Study Group. (2003). The influence of birthweight and intrauterine environment on adiposity and fat distribution in later life. Int. J. Obes., 27, 755–77.CrossRefGoogle ScholarPubMed
, , , and (2001). Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health Perspect., 109, 675–80.CrossRefGoogle ScholarPubMed
, , et al. (2004). Bishenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br. J. Pharmacol., 141, 209–14.CrossRefGoogle ScholarPubMed
, , , and (2003). Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol. Carcinog., 38, 78–84.Google Scholar
, and (1998). DES and estradiol potentiate a lupus-like autoimmune nephritis in NZB x SWR (SNF1) mice. Toxicologist, 42, 403.Google Scholar
, , , and (2003). Cognitive development in preschool children prenatally exposed to PCBs and Me Hg. Neurotoxicol. Teratol., 25, 11–22.CrossRefGoogle Scholar
, , et al. (2001). Preimplantation exposure to bisphenol A advances postnatal development. Reprod. Toxicol., 15, 71–4.CrossRefGoogle ScholarPubMed
, , et al. (2003). Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype. Eur. J. Neurosci., 18, 589–600.CrossRefGoogle Scholar
, and (2002). 2,3,7,8-tetrachlorodibenzo-p-dioxin interacts with endogenous estradiol to disrupt prostate gland morphogenesis in male rat fetuses. Toxicol. Sci., 67, 264–74.CrossRefGoogle ScholarPubMed
, , , and (2002). Childhood obesity is associated with maternal smoking in pregnancy. Eur. J. Pediatr., 161, 445–8.CrossRefGoogle ScholarPubMed
, and (2004). Effect of the anti-androgenic endocrine disruptor vinclozolin on embryonic testis cord formation and postnatal testis development and function. Reprod. Toxicol., 18, 765–74,CrossRefGoogle ScholarPubMed
, and (2003). The eukaryotic genome: a system regulated at different hierarchical levels. J. Cell Sci., 116, 4067–75.CrossRefGoogle ScholarPubMed
, , et al. (1997). Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc. Natl. Acad. Sci. USA, 94, 2056–61.CrossRefGoogle Scholar
, , , and (1999). Low-dose bioactivity of xenoestrogens in animals: fetal exposure to low doses of methoxychlor and other xenoestrogens increases adult prostate size in mice. Toxicol. Ind. Health, 15, 12–25.CrossRefGoogle ScholarPubMed
, , and (2003). Does maternal smoking during pregnancy cause childhood overweight?Pediatr. Perinat. Epidemiol., 17, 171–9.CrossRefGoogle ScholarPubMed
and (1984). Maternal adipose tissue response to nicotine administration in the pregnant rat: effects on fetal body fat and cellularity. Br. J. Nutr., 51, 7–13.CrossRefGoogle ScholarPubMed
, and (2003). Neonatal oestrogen down-regulates prostatic androgen receptor through a proteosome-mediated protein degradation pathway. Endocrinol., 144, 4841–50.CrossRefGoogle ScholarPubMed
, , , and (2002). Levels of environmental contaminants in human follicular fluid, serum, and seminal plasma of couples undergoing in vitro fertilization. Arch. Environ. Contam. Toxicol., 43, 121–6.CrossRefGoogle ScholarPubMed
- 1
- Cited by